Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lorraine Z. Mutsvunguma"'
Autor:
Gabriela M. Escalante, Ivana G. Reidel, Lorraine Z. Mutsvunguma, Simeon Cua, Brenda A. Tello, Esther Rodriguez, Mafalda A. Farelo, Cloe Zimmerman, Murali Muniraju, He Li, Aparna N. Govindan, Michael K. Axthelm, Scott W. Wong, Javier Gordon Ogembo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionEpstein-Barr virus (EBV) is an oncogenic human herpesvirus associated with ~350,000 cases of lymphoid and epithelial malignancies every year, and is etiologically linked to infectious mononucleosis and multiple sclerosis. Despite four dec
Externí odkaz:
https://doaj.org/article/8be24fa2fe95452194f5a54a9cd0960d
Autor:
Simeon Cua, Brenda A. Tello, Mafalda A. Farelo, Esther Rodriguez, Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Javier Gordon Ogembo, Ivana G. Reidel
Publikováno v:
Viruses, Vol 16, Iss 10, p 1628 (2024)
Modified vaccinia Ankara (MVA) virus is a widely used vaccine platform, making accurate titration essential for vaccination studies. However, the current plaque forming unit (PFU) assay, the standard for MVA titration, is prone to observer bias and o
Externí odkaz:
https://doaj.org/article/6122bdc2bc06403c85a43d455514d09e
Autor:
Charles D. Warden, Preetam Cholli, Hanjun Qin, Chao Guo, Yafan Wang, Chetan Kancharla, Angelique M. Russell, Sylvana Salvatierra, Lorraine Z. Mutsvunguma, Kerin K. Higa, Xiwei Wu, Sharon Wilczynski, Raju Pillai, Javier Gordon Ogembo
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/4a7c94f3f3064fca8973e56af21ccde2
HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study
Autor:
Charles D. Warden, Preetam Cholli, Hanjun Qin, Chao Guo, Yafan Wang, Chetan Kancharla, Angelique M. Russell, Sylvana Salvatierra, Lorraine Z. Mutsvunguma, Kerin K. Higa, Xiwei Wu, Sharon Wilczynski, Raju Pillai, Javier Gordon Ogembo
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-16 (2022)
Abstract Background Human papillomavirus (HPV) is the primary cause of invasive cervical cancer (ICC). The prevalence of various HPV genotypes, ranging from oncogenically low- to high-risk, may be influenced by geographic and demographic factors, whi
Externí odkaz:
https://doaj.org/article/314f82786a814936a4a959e987f69fd1
Autor:
Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Murali Muniraju, Esther Rodriguez, Javier Gordon Ogembo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEpstein-Barr virus (EBV) is the causal agent of infectious mononucleosis and has been associated with various cancers and autoimmune diseases. Despite decades of research efforts to combat this major global health burden, there is no approv
Externí odkaz:
https://doaj.org/article/910fd12bc64b40e7b00283a915826888
Autor:
Gabriela M. Escalante, Joslyn Foley, Lorraine Z. Mutsvunguma, Esther Rodriguez, David H. Mulama, Murali Muniraju, Peng Ye, Anne K. Barasa, Javier Gordon Ogembo
Publikováno v:
Vaccines, Vol 8, Iss 2, p 169 (2020)
Primary infection with Epstein-Barr virus (EBV) is associated with acute infectious mononucleosis, whereas persistent infection is associated with chronic diseases such as autoimmune diseases and various types of cancer. Indeed, approximately 2% of a
Externí odkaz:
https://doaj.org/article/92b42604895541918b1d68851a524325
Autor:
Xiwei Wu, Murali Muniraju, Charles Warden, John C. Williams, Esther Rodriguez, Anne K. Barasa, Waithaka Mwangi, Lorraine Z. Mutsvunguma, Gabriela M. Escalante, Hanjun Qin, Javier Gordon Ogembo, David H. Mulama, Jinhui Wang
Publikováno v:
Virology
Prevention of Epstein-Barr virus (EBV) infection has focused on generating neutralizing antibodies (nAbs) targeting the major envelope glycoprotein gp350/220 (gp350). In this study, we generated 23 hybridomas producing gp350-specific antibodies. We c
Autor:
Felix Wussow, Javier Gordon Ogembo, Lorraine Z. Mutsvunguma, Gabriela M. Escalante, Esther Rodriguez, Anne K. Barasa, Jennifer Totonchy, Joslyn Foley, Ramina Nabiee, David H. Mulama, Murali Muniraju, Peng Ye
Publikováno v:
Vaccine. 37:4184-4194
Kaposi sarcoma-associated herpesvirus (KSHV) is an emerging pathogen and the causative agent of multiple cancers in immunocompromised patients. To date, there is no licensed prophylactic KSHV vaccine. In this study, we generated a novel subunit vacci
Autor:
Anne K. Barasa, Esther Rodriguez, Joslyn Foley, Murali Muniraju, Peng Ye, Gabriela M. Escalante, David H. Mulama, Lorraine Z. Mutsvunguma, Javier Gordon Ogembo
Publikováno v:
Vaccines, Vol 8, Iss 169, p 169 (2020)
Vaccines
Volume 8
Issue 2
Vaccines
Volume 8
Issue 2
Primary infection with Epstein-Barr virus (EBV) is associated with acute infectious mononucleosis, whereas persistent infection is associated with chronic diseases such as autoimmune diseases and various types of cancer. Indeed, approximately 2% of a
Autor:
Michael A. Brehm, Joshua Nyagol, Anne K. Barasa, Jennifer Totonchy, Javier Gordon Ogembo, Felix Wussow, Gabriela M. Escalante, Lorraine Z. Mutsvunguma, David H. Mulama, Joslyn Foley, Romina Nabiee, Esther Rodriguez, Murali Muniraju
Publikováno v:
Journal of Virology. 93
Kaposi sarcoma-associated herpesvirus (KSHV) is an emerging pathogen and is the causative infectious agent of Kaposi sarcoma and two malignancies of B cell origin. To date, there is no licensed KSHV vaccine. Development of an effective vaccine agains